Thrivent Financial for Lutherans Has $649,000 Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Thrivent Financial for Lutherans cut its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 8.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 64,851 shares of the company’s stock after selling 6,142 shares during the period. Thrivent Financial for Lutherans’ holdings in AdaptHealth were worth $649,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. GAMMA Investing LLC grew its stake in shares of AdaptHealth by 197.1% during the first quarter. GAMMA Investing LLC now owns 2,537 shares of the company’s stock worth $29,000 after purchasing an additional 1,683 shares during the period. Covestor Ltd boosted its position in shares of AdaptHealth by 279.6% during the first quarter. Covestor Ltd now owns 3,109 shares of the company’s stock worth $36,000 after buying an additional 2,290 shares during the period. Canada Pension Plan Investment Board acquired a new position in shares of AdaptHealth during the second quarter worth about $58,000. Blue Trust Inc. acquired a new position in shares of AdaptHealth during the second quarter worth about $85,000. Finally, Innealta Capital LLC bought a new stake in AdaptHealth during the second quarter worth about $101,000. 82.67% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director David Solomon Williams III sold 4,000 shares of the stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $11.26, for a total transaction of $45,040.00. Following the sale, the director now owns 36,899 shares of the company’s stock, valued at $415,482.74. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other AdaptHealth news, Director David Solomon Williams III sold 4,000 shares of the firm’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $11.26, for a total value of $45,040.00. Following the sale, the director now owns 36,899 shares of the company’s stock, valued at approximately $415,482.74. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Shaw Rietkerk sold 25,000 shares of the stock in a transaction on Friday, September 20th. The shares were sold at an average price of $11.24, for a total value of $281,000.00. Following the completion of the transaction, the chief operating officer now owns 212,611 shares of the company’s stock, valued at $2,389,747.64. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.43% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reiterated an “outperform” rating and set a $13.00 target price on shares of AdaptHealth in a report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, AdaptHealth has an average rating of “Hold” and an average price target of $10.70.

AdaptHealth Price Performance

NASDAQ:AHCO opened at $10.18 on Tuesday. The company has a quick ratio of 0.94, a current ratio of 1.15 and a debt-to-equity ratio of 1.38. The stock’s 50 day moving average price is $10.68 and its two-hundred day moving average price is $10.45. The firm has a market capitalization of $1.36 billion, a price-to-earnings ratio of -1.93, a P/E/G ratio of 1.73 and a beta of 1.10. AdaptHealth Corp. has a 12-month low of $6.37 and a 12-month high of $11.90.

AdaptHealth (NASDAQ:AHCO) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). AdaptHealth had a negative net margin of 21.20% and a positive return on equity of 9.58%. The business had revenue of $805.98 million during the quarter, compared to the consensus estimate of $802.62 million. During the same quarter in the prior year, the company earned $0.16 EPS. AdaptHealth’s quarterly revenue was up 1.6% on a year-over-year basis. On average, analysts anticipate that AdaptHealth Corp. will post 0.87 earnings per share for the current year.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.